This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Although COVID-19 has slowed the growth of drug sales, the oncology market’s total growth is driven by the targeted drugs in oncology. While that sounds encouraging, most cancer drugs launched between 2009 and 2014 cost more than USD 100,000 annually. ASH Clinical News takes it a step further.
In this episode, Samuel Adeyinka interviews Marc Toth , who shares his entrepreneurial journey in the cardiovascular medical device sales industry. We are corporate with $150 million in sales for corporate but I’ve been here since the beginning. Who is Marc Toth? Without saying too much, I’ll share with you this.
This study included 63 of 355 new therapeutic drugs and biologic agents approved by the US Food and Drug Administration between 2009 and 2018. Adding sales and medical support staff is expensive, not to mention the cost of “marketing” the drug to patients and consumers.
Humira’s net price—which subtracts discounts and rebates—increased by 110% between 2009 and 2018, from $16,663 per year to $35,041 per year. Contrary to the stated purpose of the ODA, AbbVie sought orphan drug protections for Humira even though it was a blockbuster drug with billions of dollars in sales each year.
Airways Flight 1549 in January 2009, when it hit a flock of geese, disabling both its engines. An Identity Crisis in Pharmaceutical Sales? Today in pharma, people are asking a similar question: In an era of unprecedented technology, is there still value in the human sales rep? But sales reps remain the No.
Boston is emerging as one of the hottest startup cities in the country, which is great news for sales professionals. These companies are all backed by venture capital and are currently hiring in sales roles. This is by no means an exhaustive list, but here are some great companies to consider for your next sales job. ProfitWell.
The Trailblazer Awards were established in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. The finalists are in for PM360’s 14 th annual Trailblazer Awards. HCP EDUCATION. SELF-PROMOTION.
When it comes to making sales in the medical equipment and pharmaceutical industry, there are several different techniques. There are plenty of successful sales reps who swear by it, so learning how to utilize this method can give you the upper hand against the competition. 30% liked the materials handed to them by their sales reps.
This is the second in a series of posts about Strategic Marketing and Sales Planning. BUT, you are beginning to wonder if good planning may lead to increased revenues, more targeted marketing, enhanced sales activity, etc. Perhaps your company is struggling in the wake of the 2009 economic downturn. You have a lot on your plate.
By leveraging his expertise in strategy and solutions development for top markets around the world, Aaron applies a marketing and sales lens while helping ensure things are kept simple yet impactful. Timothy White is the global head of digital at Teva Pharmaceuticals.
Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. The finalists are in for PM360’s 15 th annual Trailblazer Awards.
In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.
Angela spent a decade in pharma sales and marketing management roles with MSD and BMS, prior to staring the world’s second market access agency in 1998, which she sold to IMS Health in 2013. Alongside his work as a recognised author, speaker, moderator and industry advisor, he founded the industry-leading publication pharmaphorum in 2009.
Over the last 25 years, the headcount in the medicines manufacturing sector has fallen by 7,000 and since 2009 production volumes have fallen by nearly a third (29%), suggesting “faltering attractiveness” of the UK for manufacturing. Established trends are unfortunately firmly in the wrong direction.
In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. Conducting internal pre-sale checks and looking at your level of compliance and licenses is a vital exercise. It is also an ideal opportunity to simplify as well as harmonise.
Matt brings over 40 years of healthcare and medical device industry experience in sales, training, recruitment, and management for companies including Winthrop Laboratories, Cardiac Pacemakers Inc, and Boston Scientific.
According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas’ top products. The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008.
According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas top products. It was first launched in the US in 2008. ” Hospira isn’t the only generics company trying to bring a version of regadenoson to the US market.
The suit claimed that Biogen paid millions of dollars to doctors in the form of speaker honoraria, training fees, consulting fees, and meals to induce them to prescribe the MS drugs Avonex (interferon-beta-1a), Tysabri (natalizumab), and Tecfidera (dimethyl fumarate) between 2009 and 2014.
In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. Ex-Novartis sales representative Steven Camburn filed a whistleblower case that claimed Novartis had paid doctors up to $3,500 to participate in educational speaker programs to increase the promotion and prescription of Gilenya.
Prior to this, he founded the industry-leading publication, pharmaphorum, in 2009, which also provides broader content communications and marketing services to enable more effective customer engagement.
Simply put, it’s taking more time and money ($2B+) to get new drugs approved, and the peak sales per drug is declining. If you’re going to DIA, please j oin us at DIA Booth #2009 to start a conversation (#DIA2019) and let’s get better together. I certainly don’t think so.
A federal judge has ruled that a jury trial will be needed to resolve allegations that Indivior attempted to preserve a monopoly by switching to a sublingual film formulation of Suboxone (buprenorphine/naloxone) in 2009 from an older pill version of the product.
Instead, he shifted to consulting and, after a period of time, the launch of pharmaphorum in 2009. “[My] People use different terms: they use multichannel, which is for marketing, whereas omnichannel tends to imply more bringing in the sales calls and the people as well.
In 2009, Edexcel Higher Education Diploma was the first college in Malaysia to introduce the new technology to the Malaysian higher education sector, and it has since become the world's leading training and research location. Since its foundation, the ITCP has excelled in four important areas.
” The pro disc C Vivo system has been in clinical use internationally since 2009 and is currently one of the most frequently implanted TDR devices in the world. I’ve found that pro disc C Vivo and pro disc C SK provide a powerful means to customize my surgical treatment to each patient.”
Created in 2009 by Stéphane Lavallée, president and chairman, eCential Robotics’ goal is to reinforce the safety and accuracy of surgical procedures, while offering simplicity and speed of use. After having recently concluded partnership with US implant companies, eCential Robotics aims from now on access to the North American market.
PrepMD was founded in 2009 with the original mission to identify, teach, inspire and connect talented individuals with the medical device community. Eventually, I progressed from a clinical role to sales and sales management before joining PrepMD in 2010. JULY 31 – We were proud to interview MedTechVet Academy Mentor, Greg Lisi.
Takeda is the largest pharmaceutical company in Japan and according to analysis by Global Insights has patents soon to expire on its best-selling products Prevacid (in 2009) and Actos (in 2111). ” Takeda’s 2007 annual report shows how net sales of Actos, a diabetic drug, showed rapid growth by reaching ¥33.7bn, a 39.1%
In the dynamic landscape of medical sales, embrace innovation, ignite change, and unleash your potential to revolutionize healthcare. Success awaits those who boldly navigate the realm of medical sales with unwavering determination and a relentless pursuit of excellence. You guys are the medical sales master podcasters.
Are you interested in helping people with heart problems as well as discovering the sales level in the medical device industry? Cardiovascular Electrophysiology Sales With Alexander Frekey. Does this type of sale require more people to buy in to utilize the heart monitors or do they get to make the decision? I like that.
He began his career in instrument reprocessing as a frontline technician in 2009, and then served as an instrument database specialist. As always, we bring you innovative guests that are doing things a little differently and bringing innovation to the medical sales space, and this is another one of those episodes. I’m doing very well.
Lee Aase: But we came up with a strategy, and then we just sort of nudged our way into things over time and then around 2009, just based on some of the success we'd seen with some of the YouTube videos we'd done and some of those other projects. My instinct was the employers would be the place to go, because then it's not individual sales.
Companies who are thinking about seeking funding via England’s new Innovative Medicines Fund (IMF) need to think through all the commercial implications, including whether spending in the IMF counts towards rebates made against sales through the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).
Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. PM360 has announced the winners of its 15 th annual Trailblazer Awards.
I have a big playlist of medical sales, medical information, news and innovation. While I was there, I met the hospice world, hospice sales and the ins and outs of hospice care. I remember back in my pharmaceutical sales rep days and I’m talking as far as 2009 or 2010. You mentioned hospice sales.
PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences.
PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. and Excitant Healthcare Advertising).
The organization also announced that Neal Dunkinson, formerly Vice President Solutions & Professional Services at Elseviers SciBite, has joined as Senior Director of Solution Sales, a new role at CCC created to support deeper collaboration with corporate customers.
If you want to apply sales techniques based on emotions, they need to function at these levels. Emotional selling is a sale technique that influences a customer's feelings to stimulate a purchasing choice instead of logic or the features of the item being offered. It’s not sales per se but more of a meaningful human interaction.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content